Loading...
Roflumilast enhances cisplatin‐sensitivity and reverses cisplatin‐resistance of ovarian cancer cells via cAMP/PKA/CREB‐FtMt signalling axis
OBJECTIVE: We previously demonstrated the roflumilast inhibited cell proliferation and increased cell apoptosis in ovarian cancer. In this study, we aimed to investigate the roles of roflumilast in development of cisplatin (DDP)‐sensitive and ‐resistant ovarian cancer. METHODS: OVCAR3 and SKOV3 were...
Na minha lista:
| Udgivet i: | Cell Prolif |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6528923/ https://ncbi.nlm.nih.gov/pubmed/30069985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12474 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|